Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
20.90
+0.60 (2.96%)
At close: Mar 27, 2026

HKG:2591 Revenue

In the year 2025, Guangzhou Innogen Pharmaceutical Group had annual revenue of 131.51M CNY. Guangzhou Innogen Pharmaceutical Group had revenue of 37.53M in the quarter ending December 31, 2025.

Revenue
131.51M CNY
Revenue Growth
n/a
P/S Ratio
65.24
Revenue / Employee
1.25M CNY
Employees
105
Market Cap
9.55B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025131.51M--
Dec 31, 2024---
Dec 31, 2023---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition